WENDT BRISTOL HEALTH SERVICES CORP
NT 10-K, 1997-04-01
SKILLED NURSING CARE FACILITIES
Previous: SAFEGUARD HEALTH ENTERPRISES INC, PRE 14A, 1997-04-01
Next: CORTECH INC, 10-K405/A, 1997-04-01



<PAGE>   1
                                UNITED STATES                    SEC File Number
                      SECURITIES AND EXCHANGE COMMISSION                     
                            Washington, D.C. 20549
                                                                   Cusip Number
                                 FORM 12b-25                                   

                          NOTIFICATION OF LATE FILING

(Check One)  X  Form 10-K     Form 20-F    Form 11-K     Form 10-Q    Form N-SAR
            ---           ---          ---           ---           ---
                 For Period Ended: December 31, 1996
                                   ---------------------
                 [  ]     Transition Report on Form 10-K
                 [  ]     Transition Report on Form 20-F
                 [  ]     Transition Report on Form 11-K
                 [  ]     Transition Report on Form 10-Q
                 [  ]     Transition Report on Form N-SAR
                 For the Transition Period Ended:                            
                                                 ----------------------------

 READ INSTRUCTION (ON BACK PAGE) BEFORE PREPARING FORM, PLEASE PRINT OR TYPE.
   Nothing in this form shall be construed to imply that the Commission has
                  verified any information contained herein.
- --------------------------------------------------------------------------------
    If the notification relates to a portion of the filing checked above,
           identify the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------

PART I - REGISTRANT INFORMATION


- --------------------------------------------------------------------------------
Full Name of Registrant

  THE WENDT BRISTOL HEALTH SERVICES CORPORATION
- --------------------------------------------------------------------------------
Former Name if Applicable


- --------------------------------------------------------------------------------
Address of Principal Executive Office (STREET AND NUMBER)

  TWO NATIONWIDE PLAZA, SUITE 760
- --------------------------------------------------------------------------------
City, State and Zip Code

  COLUMBUS, OHIO 43215
- --------------------------------------------------------------------------------

PART II - RULES 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed.  (Check box if appropriate)

     |   (a)     The reasons described in reasonable detail in Part III of this
     |           form could not be eliminated without unreasonable effort or
     |           expense;
     |  
     |   (b)     The subject annual report, semi-annual report, transition
     |           report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion
     |           thereof, will be filed on or before the fifteenth calendar day
  X  |           following the prescribed due date; or the subject quarterly
 --- |           report of transition report on Form 10-Q, or portion thereof
     |           will be filed on or before the fifth calendar day following
     |           the prescribed due date; and
     | 
     |   (c)     The accountant's statement or other exhibit required by Rule
     |           12b-25(c) has been attached if applicable.
     
PART III - NARRATIVE

State below in reasonable detail the reasons why the Forms 10-K, 20-F, 11-K,
10-Q, N-SAR, or the transition report or portion thereof, could not be filed
within the prescribed time period.  

SEE ATTACHMENT "A"                              (ATTACH EXTRA SHEETS IF NEEDED)
                                                                SEC 1344 (6/94)
<PAGE>   2

PART IV - OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this
         notification

           CHARLES R. CICERCHI           614          221-6000
         ----------------------------  ----------   ---------------------
                   (Name)              (Area Code)    (Telephone Number)

(2)      Have all other periodic reports required under Section 13 or 15(d) of
         the Securities Exchange Act of 1934 or Section 30 of the Investment 
         Company Act of 1940 during the preceding 12 months or for such shorter 
         period that the registrant was required to file such report(s) been 
         filed: If answer is no, identify report(s).           X  Yes        No 
                                                              ---       ---     
                           

         ----------------------------------------------------------------------
(3)      Is it anticipated that any significant change in results of operations
         from the corresponding period for the last fiscal year will be
         reflected by the earnings statements to be included in the subject 
         report or portion thereof?                            X  Yes        No 
                                                              ---       ---     

         If so, attach an explanation of the anticipated change, both
         narratively and quantitatively, and, if appropriate, state the reasons 
         why a reasonable estimate of the results cannot be made.

           SEE ATTACHMENT "B"
         ----------------------------------------------------------------------

                THE WENDT-BRISTOL HEALTH SERVICES CORPORATIONS
                ----------------------------------------------
                 (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date          MARCH 31, 1997                  By  /s/ Charles R. Cicerchi
     --------------------------------            ------------------------------
                                                 Charles R. Cicerchi,
                                                 Vice-President Finance
                                                 Principal Financial and 
                                                 Accounting Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized-representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority
to sign on behalf of the registrant shall be filed with the form.


                                  ATTENTION

  Intentional misstatements or omissions of fact constitute Federal Criminal
                       Violations (See 18 U.S.C. 1001).

                              GENERAL INSTRUCTION

1.       This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the
         General Rules and Regulations under the Securities Exchange Act of
         1934.

2.       One signed original and four conformed copies of this form and
         amendments thereto must be completed and filed with the Securities and
         Exchange Commission, Washington, D.C. 20549 in accordance with Rule
         0-3 of the General Rules and Regulations under the Act. The
         information contained in or filed with the form will be made a matter
         of public record in the Commission files.

3.       A manually signed copy of the form and amendments thereto shall be
         filed with each national securities exchange on which any class of
         securities of the registrant is registered.

4.       Amendments to the notifications must also be filed on form 12b-25 but
         need not restate information that has been correctly furnished. The
         form shall be clearly identified as an amendment notification.

5.       ELECTRONIC FILERS.  This form shall not be used by electronic filers
         unable to timely file a report solely due to electronic difficulties.
         Filers unable to submit a report within the time period prescribed due
         to difficulties in electronic filing should comply with either Rule
         201 or Rule 202 of Regulation S-T (Section 232.201 or Section 232.202
         of this chapter) or apply for an adjustment in filing date pursuant to
         Rule 13(b) of Regulation S-T (Section 232.13(b) of this chapter).

<PAGE>   3
                THE WENDT-BRISTOL HEALTH SERVICES CORPORATION
                                 FORM 12b-25
                         DECEMBER 31, 1996 FORM 10-K

                                ATTACHMENT "A"


PART III - NARRATIVE

Registrant has a limited number of financial and accounting personnel.
Significant priority time has been devoted in recent weeks to, among other
issues, the following matters:

       (a)  Formation of a limited liability company and the subsequent
            purchase of the assets of a diagnostic center.

       (b) Formation of a limited liability company and the related start-up of 
           a radiation therapy clinic.

       (c) Completion of a bond issuance to replace an existing working capital
           financing arrangement.

       (d) Preparation and audit of two subsidiaries' annual reports to the U.S.
           Department of HUD.

Disclosures of (a) through (c) will be included in the Form 10-K.













<PAGE>   4
                THE WENDT-BRISTOL HEALTH SERVICES CORPORATION
                                 FORM 12b-25
                         DECEMBER 31, 1996 FORM 10-K

                                ATTACHMENT "B"


PART IV - OTHER INFORMATION

It is anticipated that primarily as a result of a decline in operating profits
at the skilled nursing facilities, the fourth quarter will produce a loss that
will contribute to the company having an estimated net loss for the calendar 
year of $200,000, after estimated depreciation of $965,000.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission